From Cheerios box trade dress to generic “googling” to a blockbuster U.S. Supreme Court decision, 2017 was another bumper year for major rulings in trademark law. Here are the 10 you need to remember.
A court hearing on a motion by drug maker Pfizer Inc. to bar Alpharma Inc. from rolling out a generic version of the Pfizer epilepsy drug Neurontin has been postponed until Oct. 1, Alpharma said on Monday.
The 15,000-member American Intellectual Property Law Association (AIPLA) says it supports, for the most part, a plan by the National Academy of Sciences to revamp the U.S. patent system.
A partner in Foley & Lardner’s intellectual property department faces possible jail time after being convicted of driving away from a traffic officer and leading the officer on a brief pursuit.
Chip equipment maker Applied Materials Inc. has agreed to pay rival Novellus Systems Inc. $8 million to dismiss patent litigation between the two companies, ending a seven-year legal spat.
A decision-making panel of the European Union has once again postponed a decision on a controversial proposal to introduce software patents in the region.
The judge presiding over Pfizer’s lawsuit against generics maker Alpharma Inc. over patent rights to the epilepsy drug Neurontin has adjourned a preliminary-injunction hearing until Monday morning.
Chinese chip maker Semiconductor Manufacturing International Corp. (SMIC) has hinted it wants to settle a patent infringement lawsuit with Taiwanese rival Taiwan Semiconductor Manufacturing Co. (TSMC), according to Taiwanese news reports.
Cooley Godward LLP has hired two seasoned biotech patent attorneys to work in its Reston, Virginia office, the firm said.
A decision by the European Court of Justice will force European trademark authorities to consider the registration of a last name as a trademark.
A bill to overhaul the much-maligned $200 million U.S. copyright arbitration system has been approved by the Senate Judiciary Committee.
Gen-Probe will pay $22.5 million to eliminate future royalty payments and settle its patent litigation against Abbott Laboratories unit Vysis, Inc. over products for clinical diagnostics and blood screening, the company said.
A federal jury in South Carolina has found two patents at the center of a lawsuit filed by textile and chemical manufacturing company Milliken & Company invalid, handing a victory to defendants Interface, Inc. and Mohawk Carpet Corp.
In a decision that could curtail patent enforcement in the European Union and force companies to file intellectual property lawsuits separately in each country, an advocate-general has advised the European Court of Justice in Luxembourg to rule that that member states can't impose orders blocking the use of a patent across the region.
Two privately-held New Hampshire companies have sued a Texas-based rival for infringement of patents covering wired and wireless internet access to customers in hotels and airports across the country.
Attorneys for legendary civil rights activist Rosa Parks say their client suffers from dementia and should not be forced to answer questions in her trademark and rights-of-publicity lawsuit against the rap group Outkast.
A federal judge in New York has ruled for DC Comics, which owns the Superman franchise, in a trademark suit against Ingersoll-Rand's Kryptonite Corp., a bicycle lock maker that adopted the name of the metal fatal to the man of steel.
A German court has dismissed Metaspinner’s lawsuit against Google Inc. over claims the internet search engine allows rival companies to buy ads using trademarked terms.
A federal jury has awarded a small software maker $82 million in damages after finding that Japanese electronics maker Sony Corp. infringed patents for a technology that lets video game controllers vibrate in-sync with on-screen effects.
Swiss pharmaceutical company Novartis AG has sued Israeli generics maker Teva Pharmaceutical Industries Ltd. to block a generic version of its hypertension drug Lotrel.
Japanese automaker Suzuki Motor has reached a settlement with the Chinese companies accused of ripping off its designs.